There is a particular kind of fear that settles in after a lung cancer diagnosis — not just fear of the disease, but fear of ...

Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a one-size-fits-all approach. Biomarkers serve diagnostic, prognostic, and predictive roles ...

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces challenges in uptake and education. Multistakeholder partnerships and ...

Background: Biomarker testing is essential for guiding first-line treatment decisions in metastatic non–small cell lung cancer (mNSCLC). Despite guideline recommendations, real-world testing patterns ...

Even as biomarker testing has become increasingly important for selecting the right lung cancer treatment, the time it takes to order these tests hasn't improved. Overall, the time from biopsy to ...

“It's My Wish, We Need This Program”: Qualitative Reflections From People With High-Grade Brain Cancer Consenting to Postmortem Brain Donation Targeted therapy has transformed treatment of non–small ...

Toward Sustainable Hematology/Oncology Fellowship Training Through Career-Aligned Specialization This retrospective study included patients with stage IIIB/IIIC/IV NSCLC treated within ONCare Alliance ...

In this interview with Targeted Oncology managing editor Sabrina Serani, Estelamari Rodriguez, MD, MPH, hematologist-oncologist at Sylvester Comprehensive Cancer Center, discusses ...

Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer biomarkers in the blood. The new technology could one day make it possible to ...

When Garen was diagnosed with lung cancer, biomarker testing helped focus his treatment options, inform his treatment decisions, and finding the appropriate treatment has allowed him to maintain his ...

Biomarker testing helps doctors create personalized cancer treatments with fewer side effects. Many health insurers deny coverage for this testing, calling it "experimental." Lack of insurance ...